Laboratory of Genetics and Biochemistry(LAGENBIO);
University of Zaragoza;
Faculty of Veterinary Sciences;
Instituto de Investigación Sanitaria de Aragón(IIS);
IA2;
CIBERNED;
Zaragoza;
Spain;
Hospital Clínico Universitario Lozano Blesa;
Zaragoza;
Spain;
Neurology Department;
ALS Unit;
CIBERER U-723;
Health Research Institute;
Madrid;
Spain;
anti-tumor and anti-angiogenic properties; C1 domain; COL19A1 gene and protein levels; compensatory effect; FACIT collagens; hippocampal interneurons; matricryptins; multiplexins; NC1 domain; regenerative response; skeletal muscle; type XIX collagen;